Air disinfection system is proven to lower risk of infection and combat respiratory illness from exposure to airborne contaminants in operating rooms
U.S.-based Aerobiotix, an innovative clinical manufacturing company, is on a mission to improve the air quality in operating rooms. Thanks to a new distribution agreement with Cardinal Health, its technology will soon be available in more hospitals and surgical centers to help reduce the risk of infection and contamination of infectious aerosols including SARS-COV-2.
Inc. magazine revealed the 2021 list of the fastest growing companies in America and Aerobiotix, an innovative medical device company, ranked 304th out of 5,000.
Aerobiotix is pleased to partner with Aerobiovac to bring our leading air disinfection technology to Canada.
MIAMISBURG, Ohio–(BUSINESS WIRE)–Aerobiotix, Inc., a leading manufacturer of air treatment devices for hospitals and healthcare, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.
Aerobiotix today announced a strategic partnership with the Association for Professionals in Infection Control and Epidemiology (APIC)